These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 20121573)

  • 21. Duration of viral shedding and factors associated with prolonged shedding among inpatients with influenza treated with oseltamivir: a prospective cohort study.
    Khoury J; Szwarcwort M; Kra-Oz Z; Saffuri M; Seh K; Yahalomi T; Braun E; Azzam ZS; Paul M; Neuberger A
    Eur J Clin Microbiol Infect Dis; 2018 Feb; 37(2):319-323. PubMed ID: 29143145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pandemic Influenza A (H1N1) 2009 in India: duration of virus shedding in patients under antiviral treatment.
    Gandhoke I; Rawat DS; Rai A; Khare S; Ichhpujani RL
    Indian J Med Microbiol; 2011; 29(1):37-41. PubMed ID: 21304193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative epidemiology of pandemic and seasonal influenza A in households.
    Cowling BJ; Chan KH; Fang VJ; Lau LLH; So HC; Fung ROP; Ma ESK; Kwong ASK; Chan CW; Tsui WWS; Ngai HY; Chu DWS; Lee PWY; Chiu MC; Leung GM; Peiris JSM
    N Engl J Med; 2010 Jun; 362(23):2175-2184. PubMed ID: 20558368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pandemic (H1N1) 2009 virus infection: persistent viral shedding after Oseltamivir treatment.
    Kanchana S; Kanchana S; Chuntrakul C; Malathum K; Prachayangprecha S; Poovorawan Y
    J Infect; 2011 Oct; 63(4):295-9. PubMed ID: 21840339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial.
    Wang C; Cao B; Liu QQ; Zou ZQ; Liang ZA; Gu L; Dong JP; Liang LR; Li XW; Hu K; He XS; Sun YH; An Y; Yang T; Cao ZX; Guo YM; Wen XM; Wang YG; Liu YL; Jiang LD
    Ann Intern Med; 2011 Aug; 155(4):217-25. PubMed ID: 21844547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis.
    Hayden FG; Belshe R; Villanueva C; Lanno R; Hughes C; Small I; Dutkowski R; Ward P; Carr J
    J Infect Dis; 2004 Feb; 189(3):440-9. PubMed ID: 14745701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiological and clinical features of 308 hospitalized patients with novel 2009 influenza A (H1N1) virus infection in China during the first pandemic wave.
    Zhang G; Xia Z; Liu Y; Li X; Tan X; Tian Y; Liang L; Nie G; Zhou B
    Intervirology; 2011; 54(3):164-70. PubMed ID: 21051903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oseltamivir: a review of its use in influenza.
    McClellan K; Perry CM
    Drugs; 2001; 61(2):263-83. PubMed ID: 11270942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of a new bioequivalent formulation of oseltamivir (Enfluvir®) on 2010-2011 seasonal influenza viruses: an open phase IV study.
    Ceyhan M; Karadag Oncel E; Badur S; Ciblak MA; Alhan E; Celik US; Kurugol Z; Saz EU; Ozsurekci Y; Celik M; Parlakay AO
    Int J Infect Dis; 2012 Apr; 16(4):e273-8. PubMed ID: 22310296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials.
    Halloran ME; Hayden FG; Yang Y; Longini IM; Monto AS
    Am J Epidemiol; 2007 Jan; 165(2):212-21. PubMed ID: 17088311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pandemic H1N1 virus transmission and shedding dynamics in index case households of a prospective Vietnamese cohort.
    Thai PQ; Mai le Q; Welkers MR; Hang Nle K; Thanh le T; Dung VT; Yen NT; Duong TN; Hoa le NM; Thoang DD; Trang HT; de Jong MD; Wertheim H; Hien NT; Horby P; Fox A
    J Infect; 2014 Jun; 68(6):581-90. PubMed ID: 24491598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The natural viral load profile of patients with pandemic 2009 influenza A(H1N1) and the effect of oseltamivir treatment.
    Li IW; Hung IF; To KK; Chan KH; Wong SS; Chan JF; Cheng VC; Tsang OT; Lai ST; Lau YL; Yuen KY
    Chest; 2010 Apr; 137(4):759-68. PubMed ID: 20061398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Household Transmission of Influenza Virus From Index Patients Treated With Baloxavir Marboxil or Neuraminidase Inhibitors: A Health Insurance Claims Database Study.
    Komeda T; Takazono T; Hosogaya N; Ogura E; Fujiwara M; Miyauchi H; Ajisawa Y; Iwata S; Watanabe H; Honda K; Kitanishi Y; Hara K; Mukae H
    Clin Infect Dis; 2021 Jun; 72(11):e859-e867. PubMed ID: 33103200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Duration of viral shedding in patients admitted to hospital with pandemic influenza A/H1N1 2009 infection.
    Na S; Chong YP; Kim MN; Kim WY; Kim W; Hong SB; Lim CM; Koh Y; Kwon JW; Hong SJ; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    J Med Virol; 2011 Jan; 83(1):5-9. PubMed ID: 21108333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuraminidase inhibitors for preventing and treating influenza in children.
    Wang K; Shun-Shin M; Gill P; Perera R; Harnden A
    Cochrane Database Syst Rev; 2012 Jan; 1():CD002744. PubMed ID: 22258949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A school outbreak of pandemic (H1N1) 2009 infection: assessment of secondary household transmission and the protective role of oseltamivir.
    Leung YH; Li MP; Chuang SK
    Epidemiol Infect; 2011 Jan; 139(1):41-4. PubMed ID: 20561390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial.
    Finberg RW; Lanno R; Anderson D; Fleischhackl R; van Duijnhoven W; Kauffman RS; Kosoglou T; Vingerhoets J; Leopold L
    J Infect Dis; 2019 Mar; 219(7):1026-1034. PubMed ID: 30428049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of self-swab for virologic confirmation of influenza virus infections in a community setting.
    Ip DK; Schutten M; Fang VJ; Fung RO; Dutkowski RT; Chan KH; Leung GM; Peiris JS; Cowling BJ
    J Infect Dis; 2012 Feb; 205(4):631-4. PubMed ID: 22198963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Viral loads and duration of viral shedding in adult patients hospitalized with influenza.
    Lee N; Chan PK; Hui DS; Rainer TH; Wong E; Choi KW; Lui GC; Wong BC; Wong RY; Lam WY; Chu IM; Lai RW; Cockram CS; Sung JJ
    J Infect Dis; 2009 Aug; 200(4):492-500. PubMed ID: 19591575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A part-randomized study of intravenous oseltamivir in adolescents and adults.
    Várkonyi I; Chappey C; Giraudon M; Burleigh L
    Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1181-8. PubMed ID: 25678009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.